SION-719 + Placebo-to-match SION-719
Phase 2Recruiting 0 views this week 0 watching💤 Quiet
Interest: 36/100
36
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Cystic Fibrosis (CF)
Conditions
Cystic Fibrosis (CF)
Trial Timeline
Nov 3, 2025 → Jul 1, 2026
NCT ID
NCT07108153About SION-719 + Placebo-to-match SION-719
SION-719 + Placebo-to-match SION-719 is a phase 2 stage product being developed by Sionna Therapeutics for Cystic Fibrosis (CF). The current trial status is recruiting. This product is registered under clinical trial identifier NCT07108153. Target conditions include Cystic Fibrosis (CF).
What happened to similar drugs?
20 of 20 similar drugs in Cystic Fibrosis (CF) were approved
Approved (20) Terminated (7) Active (0)
Hype Score Breakdown
Clinical
12
Activity
15
Company
9
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT07108153 | Phase 2 | Recruiting |
Competing Products
20 competing products in Cystic Fibrosis (CF)